156 related articles for article (PubMed ID: 30756327)
1. Minimally Invasive Intact Excision of High-Risk Breast Lesions and Small Breast Cancers: The Intact Percutaneous Excision (IPEX) Registry.
Whitworth P; Schonholz S; Phillips R; Robertson Y; Ruiz A; Winchester S; Graham C; Simpson J; Wernecke C
Ann Surg Oncol; 2019 Apr; 26(4):954-960. PubMed ID: 30756327
[TBL] [Abstract][Full Text] [Related]
2. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract][Full Text] [Related]
3. The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
Polat AV; Soran A; Andacoglu O; Kamali Polat A; McGuire K; Diego E; Johnson R
J BUON; 2013; 18(3):601-7. PubMed ID: 24065470
[TBL] [Abstract][Full Text] [Related]
4. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the frequency of upgrade to malignancy following surgical excision of high-risk breast lesions and ductal carcinoma in situ identified by core needle biopsy.
Allen A; Cauthen A; Dale P; Jean-Louis C; Lord A; Smith B
Breast J; 2019 Jan; 25(1):103-106. PubMed ID: 30461129
[TBL] [Abstract][Full Text] [Related]
6. Definitive diagnosis for high-risk breast lesions without open surgical excision: the Intact Percutaneous Excision Trial (IPET).
Whitworth PW; Simpson JF; Poller WR; Schonholz SM; Turner JF; Phillips RF; Johnson JM; McEachin FD
Ann Surg Oncol; 2011 Oct; 18(11):3047-52. PubMed ID: 21947585
[TBL] [Abstract][Full Text] [Related]
7. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
8. High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision.
Bahl M; Barzilay R; Yedidia AB; Locascio NJ; Yu L; Lehman CD
Radiology; 2018 Mar; 286(3):810-818. PubMed ID: 29039725
[TBL] [Abstract][Full Text] [Related]
9. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
10. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
11. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
12. Intact Percutaneous Excision (IPEX) for Definitive Diagnosis of High-Risk Breast Lesions.
Whitworth PW
Ann Surg Oncol; 2011 Oct; 18(11):3095. PubMed ID: 21904961
[TBL] [Abstract][Full Text] [Related]
13. Lack of definitive presurgical pathological diagnosis is associated with inadequate surgical margins in breast-conserving surgery.
Nasute Fauerbach PV; Tyryshkin K; Rodrigo SP; Rudan J; Fichtinger G; Reedijk M; Varma S; Berman DM
Eur J Surg Oncol; 2021 Oct; 47(10):2483-2491. PubMed ID: 34120811
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
15. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
16. Margin-free excision of small solid breast carcinomas using the Intact Breast Lesion Excision System
Papapanagiotou IK; Koulocheri D; Kalles V; Liakou P; Michalopoulos NV; Al-Harethee W; Georgiou G; Matiatou M; Nonni A; Pazaiti A; Theodoropoulos GE; Menenakos E; Zografos GC
Breast Cancer; 2018 Mar; 25(2):134-140. PubMed ID: 28918560
[TBL] [Abstract][Full Text] [Related]
17. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
18. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution.
McGhan LJ; McKeever SC; Pockaj BA; Wasif N; Giurescu ME; Walton HA; Gray RJ
Ann Surg Oncol; 2011 Oct; 18(11):3096-101. PubMed ID: 21947587
[TBL] [Abstract][Full Text] [Related]
19. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
